Software Healthcare Sector

Biome Grow

Market Cap: US$112.0

Focuses on the cannabis business.

VMS Rehab Systems

Market Cap: US$111.0

Engages in generic drug and home healthcare businesses.

RVL Pharmaceuticals

Market Cap: US$111.0

Operates as a specialty pharmaceutical company in the United States, Argentina, and Hungary.

James E. Wagner Cultivation

Market Cap: US$109.0

Through its subsidiary, James E.

Green and Hill Industries

Market Cap: US$103.0

Green and Hill Industries, Inc., doing business as Ross’ Gold, distributes medical cannabis strains for various ailments and illnesses in Canada.

Navidea Biopharmaceuticals

Market Cap: US$99.0

A biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics.

Valeo Pharma

Market Cap: US$98.0

Operates as a pharmaceutical company focused on licensing, acquiring, and commercializing drugs.

Cognetivity Neurosciences

Market Cap: US$93.0

Operates as a technology company.

Antigenics

Market Cap: US$91.0

A clinical-stage biopharmaceutical company, discovers, manufactures, and develops immunotherapies for cancer.

MJardin Group

Market Cap: US$90.0

Through its subsidiaries, cultivates, harvests, processes, and sells cannabis products in Canada and the United States.

GAMERICA Holdings and Acquisitions

Market Cap: US$88.0

Develops software applications in the United States.

RenovaCare

Market Cap: US$87.0

A development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications.

Alliance Growers

Market Cap: US$85.0

Engages in acquiring investments in and developing projects in the medical cannabis sector in British Columbia.

Chalice Brands

Market Cap: US$84.0

Engages in the retail, production, processing, wholesale, and distribution of cannabis products.

TPT Strategic

Market Cap: US$80.0

Develops a telehealth platform for patients and hospitals.

Response Genetics

Market Cap: US$77.0

A life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally.

Avivagen

Market Cap: US$77.0

Focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity.

Winston Pharmaceuticals

Market Cap: US$77.0

A pharmaceutical company, discovers, develops, and commercializes therapeutics for pain management.

CannAmerica Brands

Market Cap: US$73.0

Owns a portfolio of brands of medical cannabis and recreational cannabis products.

Indigenous Bloom Hemp

Market Cap: US$71.0

Focuses on the production of hemp products.

Interpharm Holdings

Market Cap: US$66.0

Develops, manufactures, and markets generic prescription strength and over-the-counter pharmaceuticals.

North Bud Farms

Market Cap: US$66.0

Through its subsidiaries, focuses on the production of pharmaceutical-grade cannabis and food grade cannabinoid infused inputs for the pharmaceutical and recreational cannabis markets in Canada.

Stem Holdings

Market Cap: US$66.0

Does not have significant operations.

Sunnylife Global

Market Cap: US$63.0

Owns and operates hospitals in China.

IMRIS

Market Cap: US$62.0

Designs, manufactures, and sells image-guided therapy solutions worldwide.

Inyx

Market Cap: US$53.0

Through its wholly-owned subsidiaries, operates as a specialty pharmaceutical company in the United States, Canada, and Europe.

Orthometrix

Market Cap: US$53.0

Develops technologies, procedures, and devices to help increase musculoskeletal mobility, as well as non-invasive technologies to treat the pain associated with osteoarthritis, plantar fasciitis, and other musculoskeletal conditions that reduce mobility.

Panacos Pharmaceuticals

Market Cap: US$53.0

A development stage biotechnology company, engages in the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases.

Baudax Bio

Market Cap: US$52.0

A biotechnology company, develops and commercializes products for hospital and other acute care related settings.

Core One Labs

Market Cap: US$47.0

Operates as a psychedelic research and development company.

GP Solutions

Market Cap: US$47.0

Provides growing systems for growing specialty and leaf crops, and herbs.

Mymetics

Market Cap: US$45.0

Engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland.

Scopus BioPharma

Market Cap: US$42.0

A clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases with unmet medical needs.

Skylight Health Group

Market Cap: US$41.0

Operates as a healthcare services and technology company in the United States.

Integrative Health Technologies

Market Cap: US$40.0

Provides fee-based clinical trials, research and development, and consulting and testing services to the healthcare and nutritional industries.

Nemaura Medical

Market Cap: US$40.0

A medical technology company, manufactures continuous glucose monitoring system in the United States.